Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002047 · ClinicalTrials.gov registry record · NA
Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
A NA study, sponsored by Glaxo Wellcome.
- Completed
- Registry status
- NA
- Development phase
NCT00002047: Completed NA study, sponsored by Glaxo Wellcome.
NCT00002047 is a NA study that has completed, run by Glaxo Wellcome. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002047, a NA study, has completed, sponsored by Glaxo Wellcome.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in HIV-infected patients in renal failure receiving maintenance hemodialysis.
Interventions
- DRUG Zidovudine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002047 record still lists
NCT00002047 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Zidovudine is the first listed.
NCT00002047 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002047 about?
NCT00002047 is a clinical study titled "Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure". To evaluate the safety, tolerance, and pharmacokinetics of Retrovir (AZT) administration in HIV-infected patients in renal failure receiving maintenance hemodialysis.
What is the current status of trial NCT00002047?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002047?
The interventions under investigation include: Zidovudine (DRUG).
Who is sponsoring clinical trial NCT00002047?
This trial is sponsored by Glaxo Wellcome, which has 65 total clinical trials registered on ClinicalTrials.gov.